首页> 中文期刊> 《心血管康复医学杂志》 >缬沙坦改善高血压合并糖耐量异常患者内皮功能和炎症因子水平

缬沙坦改善高血压合并糖耐量异常患者内皮功能和炎症因子水平

         

摘要

Objective: To study effects of angiotensin II receptor blocker valsartan on plasma levels of nitric oxide (NO), endothelin (ET) and inflammatory factors in patients with essential hypertension (EH) complicated impaired glucose tolerance (IGT). Methods: A total of 42 EH + IGT patients were given valsartan 80 mg oral, once a day, and another 40 healthy adults were regard as normal control group. Detections were performed on blood glucose, 2h postprandial blood glucose (2hPG) , homeostasis model-insulin resistance index (HOMA- IR) , levels of NO and serum inflammatory factors in the two groups before and after treatment. Results: Compared with normal control group, levels of blood pressure, 2hPG, HOMA-IR, tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6) and ET significantly increased, and NO level significantly decreased in EH + IGT group (P<0. 01) s compared with before treatment, there were significant decrease in levels of blood pressure [(163. 95±8. 0) / (99.10±ll. 8) mm-Hg vs. (132. 93±10. 7) / (82.14±9. 5) mmHg], 2hPG [(9.10±l. 10) mmol/L vs. (7. 85±1.15) mmol/L], HO-MA-IR[(3. 90±2.11) vs. (2.73 ±1.71)], plasma ET [ (47. 84 ±7.79) ng/L vs. (31.84 ±4.5) ng/L], TNF-a[ (32.30 ±5.49) ng/L vs. (26. 83±4.83) ng/L] and IL-6 [(112.70 ±24.79) ng/L vs. (77. 22±11. 53) ng/L] and significant increase in plasma level of NO [ (38.1±7. 36) f*mol/L vs. (43. 38±7. 52) nmol/L] in EH + IGT group after eight-week treatment with valsartan, P

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号